Vážení uživatelé, vítáme Vás v nové podobě uživatelského rozhraní Repozitáře publikační činnosti UK. Budeme rádi, když nám věnujete chvíli Vašeho času a poskytnete nám k nové podobě repozitáře zpětnou vazbu.

Dear users, welcome to the new interface of the Charles University Publication Repository. We would appreciate it if you could take a moment of your time to provide us with feedback on the new design of the repository.

Dotazník pro zpětnou vazbu je dostupný na URL adrese / The feedback questionnaire is available at the URL address: https://forms.office.com/e/ueBL8SYPZt

Zobrazit minimální záznam

Pentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respiration

dc.contributor.authorLeischner Fialova, Jindriska
dc.contributor.authorHönigova, Katerina
dc.contributor.authorRaudenska, Martina
dc.contributor.authorMikšátková, Lucie
dc.contributor.authorZobalova, Renata
dc.contributor.authorNavratil, Jiri
dc.contributor.authorŠmigová, Jana
dc.contributor.authorMoturu, Taraka Ramji
dc.contributor.authorVicar, Tomas
dc.contributor.authorBalvan, Jan
dc.contributor.authorVeselá, Kateřina
dc.contributor.authorAbramenko, Nikita
dc.contributor.authorKejík, Zdeněk
dc.contributor.authorKaplánek, Robert
dc.contributor.authorGumulec, Jaromir
dc.contributor.authorRösel, Daniel
dc.contributor.authorMartásek, Pavel
dc.contributor.authorBrábek, Jan
dc.contributor.authorJakubek, Milan
dc.contributor.authorNeužil, Jiří
dc.contributor.authorMasařík, Michal
dc.date.accessioned2023-04-18T07:40:27Z
dc.date.available2023-04-18T07:40:27Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.14178/1851
dc.description.abstractMitochondria generate energy and building blocks required for cellular growth and function. The notion that mitochondria are not involved in the cancer growth has been challenged in recent years together with the emerging idea of mitochondria as a promising therapeutic target for oncologic diseases. Pentamethinium salts, cyan dyes with positively charged nitrogen on the benzothiazole or indole part of the molecule, were originally designed as mitochondrial probes. In this study, we show that pentamethinium salts have a strong effect on mitochondria, suppressing cancer cell proliferation and migration. This is likely linked to the strong inhibitory effect of the salts on dihydroorotate dehydrogenase (DHODH)-dependent respiration that has a key role in the de novo pyrimidine synthesis pathway. We also show that pentamethinium salts cause oxidative stress, redistribution of mitochondria, and a decrease in mitochondria mass. In conclusion, pentamethinium salts present novel anti-cancer agents worthy of further studies.en
dc.language.isoen
dc.relation.urlhttps://doi.org/10.1016/j.biopha.2022.113582
dc.rightsCreative Commons Uveďte původ 4.0 Internationalcs
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.titlePentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respirationen
dcterms.accessRightsopenAccess
dcterms.licensehttps://creativecommons.org/licenses/by/4.0/legalcode
dc.date.updated2023-10-02T06:16:39Z
dc.subject.keywordDihydroorotate dehydrogenaseen
dc.subject.keywordMetastasisen
dc.subject.keywordMigrationen
dc.subject.keywordMitochondriaen
dc.subject.keywordPentamethinium saltsen
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/SVV/SVV260521
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/UNCE/MED/UNCE/MED/007
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/PROGRES/Q38
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/PROGRES/Q27
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM/LM/LM2018133
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MPO/FV/FV40120
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/TA0/TN/TN01000013
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/TA0/FW/FW02020128
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MZ0/NU/NU21-08-00407
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM/OP VVV/CZ.02.1.01/0.0/0.0/16_019/0000785
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM/EF/EF16_019/0000785
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM/LM/LM2018129
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/PROGRES/Q26
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM//LX22NPO5102
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/COOP/COOP
dc.date.embargoStartDate2023-10-02
dc.type.obd73
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.1016/j.biopha.2022.113582
dc.identifier.utWos000855198000002
dc.identifier.eidScopus2-s2.0-85137077593
dc.identifier.obd615474
dc.identifier.rivRIV/00216208:11310/22:10447815
dc.identifier.rivRIV/00216208:11110/22:10447815
dc.identifier.rivRIV/00064165:_____/22:10447815
dc.identifier.pubmed36055111
dc.subject.rivPrimary30000::30100
dcterms.isPartOf.nameBiomedicine & Pharmacotherapy
dcterms.isPartOf.issn0753-3322
dcterms.isPartOf.journalYear2022
dcterms.isPartOf.journalVolume154
dcterms.isPartOf.journalIssueOctober
uk.faculty.primaryId108
uk.faculty.primaryName1. lékařská fakultacs
uk.faculty.primaryNameFirst Faculty of Medicineen
uk.faculty.secondaryId115
uk.faculty.secondaryId53
uk.faculty.secondaryNamePřírodovědecká fakultacs
uk.faculty.secondaryNameFaculty of Scienceen
uk.faculty.secondaryNameVšeobecná fakultní nemocnice v Prazecs
uk.faculty.secondaryNameVšeobecná fakultní nemocnice v Prazeen
uk.department.primaryId100025448551
uk.department.primaryNameBIOCEV 1. LF UKcs
uk.department.primaryNameBIOCEVen
uk.department.secondaryId1522
uk.department.secondaryId5000002603
uk.department.secondaryId1034
uk.department.secondaryId1035
uk.department.secondaryId1036
uk.department.secondaryNameKlinika pediatrie a dědičných poruch metabolismu 1. LF a VFNcs
uk.department.secondaryNameDepartment of Paediatrics and Inherited Metabolic Disorders 1. LF UK a VFNen
uk.department.secondaryNameKlinika pediatrie a dědičných poruch metabolismu 1.LF a VFNcs
uk.department.secondaryNameKlinika pediatrie a dědičných poruch metabolismu 1.LF a VFNen
uk.department.secondaryNameKatedra genetiky a mikrobiologiecs
uk.department.secondaryNameDepartment of Genetics and Microbiologyen
uk.department.secondaryNameKatedra buněčné biologiecs
uk.department.secondaryNameDepartment of Cell Biologyen
uk.department.secondaryNameKatedra fyziologiecs
uk.department.secondaryNameDepartment of Physiologyen
dc.description.pageRangenestránkováno
dc.type.obdHierarchyCsČLÁNEK V ČASOPISU::článek v časopisu::původní článekcs
dc.type.obdHierarchyEnJOURNAL ARTICLE::journal article::original articleen
dc.type.obdHierarchyCode73::152::206en
uk.displayTitlePentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respirationen


Soubory tohoto záznamu

Thumbnail

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam